| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.18 | 0.4 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.13 | 0.4 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |